CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2021-08-13

Reporting Person: MCENANY PATRICK J (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-13	Common stock, par value $0.001 per share	M	100000	$3.12	Acquired	4911019	Direct
2021-08-13	Common stock, par value $0.001 per share	S	31186	$6.174	Disposed	4879833	Direct
2021-08-13	Common stock, par value $0.001 per share	S	31529	$6.0745	Disposed	4848304	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-13	Options to purchase common stock	$3.12	M	100000	Disposed	2021-08-28	Common Stock (100000)	Direct

Footnotes

F1: Shares were sold to cover exercise price of options and tax withholding requirements.

F2: Options vested in three annual tranches beginning on August 28, 2015.